KRAS and colorectal carcinoma: It’s important to note that while there is evidence suggesting an association between KRAS mutations and thrombosis in CRC, the relationship is complex and may be influenced by various factors, including the specific KRAS mutation type and the overall clinical characteristics of the patient.